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red blood cells, lymphocytes, fibroblasts, histiocytes. The signs of
tumor cell death by activation of apoptosis were observed: shrink-
age and reduction in cell volume, chromatin hyper condensation,
fragmentation of organelles and nucleus, a large amount of
coarse bundles of microfilaments, the presence of apoptotic cells.
Tumor tissue was infiltrated predominantly with CD3 and CD161a
cells, CD45a indicators decreased by 3–4.5 times.
The analysis of antitumor effect in breast cancer patients
depending on factors of energy processes inhibition revealed that
complete tumor regression only in combination with ATP
occurred in 14.2%, and D-in 18.8%, partial regression using ATP
was 71–5%, D – 62.5%. Tumor progression was not observed.
Conclusion: Modulating abnormalities in energy metabolism
due to metabolic acidosis of tumor microenvironment on the
background of systemic chemotherapy, one can achieve activa-
tion of additional pathogenetic mechanisms of inhibition of
tumor growth and tumor cell death. It is necessary to emphasize
the importance of the further search for factors of pathogenetic
mechanisms and therapy of the influence on the tumor, including
the modulation of acidosis of peritumoraly area that opens up
new perspectives in solving this problem.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.094
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Non-small cell lung cancer (NSCLC) is characterized by multi-
ple genetic alterations such as loss of heterozygosity (LOH),
microsatellite instability (MSI), promoter hypermethylation and
changes of miRNA expression. According to a field cancerization
(FC) phenomenon the adjacent histologically normal tissue plays
a role in tumor progression by triggering the transformation
process.
The aim of the study was the analysis of genetic alterations in
tumor and adjacent tissue to determine the FC size and to reveal
associations with clinico-morphological features of patients.
The study group included 135 patients with NSCLC. From each
patient 4 FFPE samples were analyzed: tumor, adjacent normal
lung tissue at 2, 5, 10 cm. LOH/MSI analysis was evaluated by
PCR using 7 microsatellite loci. Promoter hypermethylation in
genes RASSF1A FHIT, DAPK1, CDH1, CD44, TIMP3, MGMT was
investigated by methyl-sensitive PCR. The expression levels of
miRNAs let-7a, miR-155, miR-205 were measured by real-time
PCR.
Our results demonstrated that LOH/MSI occurs only in tumor
while promoter hypermethylation occurs also in adjacent tissue
at 2, 5 cm, but not at 10 cm. The downregulation of let-7a,
miR-155 in adjacent tissue is lower than in tumor. The levels of
investigated miRNAs in adjacent tissue vary depending on tumor
differentiation – in patients with differentiated tumors it is higher
than in the group with poorly differentiated tumors.
We postulate that FC size in NSCLC is at least 5 cm from tumor
and includes only epigenetic but not structural (LOH/MSI)
alterations. The evaluation of epigenetic changes in adjacent
tissue (e.g., surgical margins) can potentially be used for
postsurgical prognosis.
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Cervical cancer is one of the most common female malignan-
cies with incidence of 19.7 per 100,000 population in Russia in
2011 (Davydov, Aksel et al., 2011). Over 6000 women in Russia
die of cervical cancer annually.
The cervical cancer incidence shows a tendency towards
increasing rates among young women (Chissov, 2009). Tomsk
region has been found to be the territory of increased cancer risk
for cervical cancer. The age-standardized incidence rate is 1.87
times higher in Tomsk region than in Russia, being 20.40/0000
(Pisareva, Odintsova et al., 2012). The highest incidence of cervical
cancer is observed in women aged 15–39 years (Churuksaeva,
Kolomiets, Shpileva, 2012). The causal role of human papillo-
mavirus infections in cervical cancer has been documented
beyond reasonable doubt. Prevention of exposure to high risk
HPV types by vaccination may prove to be the most efficient
and logistically feasible preventive intervention for cervical
cancer.
Epidemiological studies conducted at the Tomsk Cancer
Research Institute have shown that the median age of patients
with cervical intraepithelial neoplasia and cervical cancer is
39.9 ± 8.5, and 89.5% of women are HPV-positive. Prevalence of
high-grade squamous intraepithelial lesion (H-SIL) peaks
between ages 25 years and 30 years.
The predominant HPV type in screened women of Tomsk
region as well as worldwide is HPV-16, reaching peak incidence
in women aged 36–40 years (74%). In the older age group (from
51 to 60 years), HPV-18 is associated with 25% of cervical cancer
cases. High prevalence of HPV-31 has been found in women under
the age of 45 years with an incidence peak (17%) in the age group
620 years.
The geographical widespread data on HPV type-distribution
are essential for estimating the impact of vaccines on cervical
cancer and cervical screening programs. Immunization against
HPV for young women aged between 9 and 26 years, with a pre-
dominant age cohort 11–13 years, was introduced in Tomsk
region in 2010. The aim of the HPV immunization program is to
protect females before they reach an age when the risk of HPV
infection increases. A total of 627 girls were vaccinated, and
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